The effect of mosapride on upper esophageal sphincter in healthy subjects

The effect of mosapride on upper esophageal sphincter in healthy subjects - Effect of mosapride on UES

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024032

Enrollment

Registered

2016-09-14

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disorder of esophageal motility

Interventions

administration of mosapride

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adults, and subjects with written informed consent

Exclusion criteria

Exclusion criteria: 1.subjects with a history of allegy for drugs 2.subjects with a history of allegy for anesthetic drug 3.subjects with a history of gastrectomy and/or vagotomy 4.subjects undergoing treatment with some disease 5.Other who are not eligible for participation judged by a doctor

Design outcomes

Primary

Measure	Time frame
resting upper esophageal sphincter pressure	—

Countries

Japan

Contacts

Public ContactHironobu Mikami

Shimane University Faculty of Medicine Second Department of Internal Medicine

d_h_m202@med.shimane-u.ac.jp0853-20-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026